
A new study has revealed that whole yellow pea flour can be used as an ingredient to produce low-glycemic foods that may help people suffering from diabetes.
During the study, researchers created banana bread, biscotti, and pasta using whole yellow pea flour and analysed the glucose responses before and after eating food products
Advertisement
However, boiled yellow peas and white bread were used as positive and negative controls.
The study showed that whole yellow pea flour banana bread and biscotti reduced glycemic responses more than whole wheat bread.
In addition, whole yellow pea flour biscotti also reduced glycemic responses more than whole-wheat flour biscotti.
"Whole yellow pea flour can be used as a functional ingredient to produce low-glycemic foods," said lead researcher Christopher Marinangeli, MSc RD.
"These findings may be used as a tool for health care practitioners to assist patients in cooking low-glycemic foods that help and prevent and manage type 2 diabetes," Marinangeli added.
The study appears in Journal of Food Science, published by the Institute of Food Technologists.
Source: ANI
SRM
In addition, whole yellow pea flour biscotti also reduced glycemic responses more than whole-wheat flour biscotti.
Advertisement
"Whole yellow pea flour can be used as a functional ingredient to produce low-glycemic foods," said lead researcher Christopher Marinangeli, MSc RD.
"These findings may be used as a tool for health care practitioners to assist patients in cooking low-glycemic foods that help and prevent and manage type 2 diabetes," Marinangeli added.
The study appears in Journal of Food Science, published by the Institute of Food Technologists.
Source: ANI
SRM
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News

A new study investigated the use of a mathematical model of glucose metabolism to assess continuous glucose monitor data as a metric of dysfunctional glycemic control.

At least 400 medicinal plants effective in decreasing sugar levels in the blood which is critical to control type 2 diabetes identified.

Considering the enormous type 2 diabetes patient population in China, a new oral insulin therapy will improve treatment.

The use of biodegradable “nanoscavengers” to restore insulin sensitivity and treat type 2 diabetes has been discovered.

DPP4 inhibitors a class of diabetes medications were found to be neutral with respect to cardiovascular events in veterans with no prior heart disease.